Alcohol use—whether light, moderate, or heavy—is linked with increasing the risk of several leading cancers, including those of the breast, colon, esophagus, and head and neck, according to evidence gathered by the American Society of Clinical Oncology (ASCO).
ALEXANDRIA, Va. – Recommendations from an American Society of Clinical Oncology (ASCO) “Summit on Addressing Obesity through Multidisciplinary Collaboration” have been published in a new article in Obesity. The recommendations cover four key areas in response to the current issues providers face in addressing obesity prevention and treatment and its impact on morbidity and mortality in the United States.
ALEXANDRIA, Va. – The majority of Americans are unaware of several major risk factors for cancer – most notably obesity, which will soon overtake smoking as the largest preventable cause of cancer in the United States. High treatment costs are compromising care: one in four people who have had cancer or have an immediate family member who has had cancer are forgoing treatment or physician visits because of the expense. In addition, nearly three-quarters of Americans support greater federal investment in cancer research, even if it means higher taxes or adding to the deficit. These are a few of the many findings from the American Society of Clinical Oncology (ASCO)’s National Cancer Opinion Survey, a large, nationally representative survey conducted online by Harris Poll.
The American Society of Clinical Oncology (ASCO) has grave concerns about the Trump Administration’s executive order calling in part for federal rules to encourage association health plans. The means to achieve ASCO’s core mission requires that patients with cancer have meaningful access to high-quality care.
The Trump administration’s move to expand the rights of employers to opt out of the requirement for contraceptive coverage would have unexpected and deleterious consequences for patients of child-bearing age with cancer. Women of child-bearing age with cancer and their male partners are advised as a part of standard oncology care to practice contraception—considered as a preventive service under the Affordable Care Act—to reduce the chances of miscarriages and birth defects.
The American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) are calling for the use of more inclusive eligibility criteria for cancer clinical trials. This recommendation is in conjunction with the release of a Special Series, published today in the Journal of Clinical Oncology (JCO). The series, which includes a joint ASCO-Friends research statement, provides a comprehensive examination of eligibility criteria for cancer clinical trials with recommendations to address eligibility criteria in five specific areas: minimum age requirements for trial enrollment, HIV/AIDS status, brain metastases, organ dysfunction, and prior and concurrent malignancies.
The American Society of Clinical Oncology (ASCO) today presented Representative Leonard Lance (NJ-7) with its second annual Congressional Leadership Award in recognition of the lawmaker's exceptional commitment to supporting cancer research and treatment. The ASCO award honors a member of Congress who is a leading champion for patients and survivors of cancer, their families, and their cancer care teams.
ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that Southeastern Medical Oncology Center (SMOC) recently signed an agreement to participate in the CancerLinQ® platform, the first oncology practice in Eastern North Carolina to do so.
ALEXANDRIA, Va. – The American Society of Clinical Oncology, Inc. (ASCO®) has announced that the first three practices in Spain have received Quality Oncology Practice Initiative (QOPI®) certification through QOPI Certification Program™, LLC (QCP). The accreditations were given today at the European Society of Medical Oncology (ESMO) 2017 Congress in Madrid, Spain.
ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that West Cancer Center in Tennessee has signed an agreement to participate in the CancerLinQ® platform.
Leading national cancer organizations have released a joint position statement to guide the future of cancer health disparities research. The statement represents a unified strategy by the American Association for Cancer Research (AACR), the American Cancer Society (ACS), the American Society of Clinical Oncology (ASCO), and the National Cancer Institute (NCI) to foster cooperation across the cancer research community to ensure that all patients — regardless of social demographics, socioeconomic status, or the communities in which they live — benefit from cancer research.
The American Society of Clinical Oncology (ASCO) today issued a position statement aimed at contributing to the national dialogue on rising cancer drug prices. The statement, which asserts that any solutions must also preserve patients' access to care and foster innovation, analyzes a wide array of options and recommends that a panel of stakeholders be established to determine which proposals will be effective and develop a uniform approach for assessing the value of drugs.
ALEXANDRIA, Va. — As part of a collaborative program between CancerLinQ LLC and the Oncology Nursing Society (ONS) aimed at helping oncology practices successfully incorporate electronic health record (EHR) data into clinical operations, three ONS members completed training in June to serve in the CancerLinQ® Ambassadors Pilot Program. CancerLinQ, a health information technology platform that powerfully connects and analyzes real-world cancer care data from almost any electronic record source, provides oncologists, nurses, and other practice staff with near real-time, actionable data to improve patient care processes and outcomes.
The American Society of Clinical Oncology (ASCO) remains opposed to the revised Better Care Reconciliation Act (BCRA). Despite the changes to the legislation, released by the Senate yesterday, the bill runs counter to ASCO’s core mission, which is to ensure that patients with cancer have meaningful access to high-quality care. Moreover, it fails to meet with ASCO’s guiding principles for health reform by cutting Medicaid and eroding critical patient protections.
ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that Ascension has signed an agreement to participate in the CancerLinQ® platform. Ascension, the largest non-profit health system in the United States, includes oncology care facilities throughout the country that can benefit from CancerLinQ’s growing quality network.